[en] Spinal muscular atrophy with respiratory distress type 1 is an autosomal recessive disorder with early respiratory difficulties, distal muscle weakness, and contractures leading to foot deformities as the most striking clinical symptoms. Mutations of the gene encoding the immunoglobulin heavy chain mu-binding protein 2, mapped on chromosome 11q13, are the cause of the disease. We present the clinical and mutational characteristics of ten patients in the Netherlands who showed considerable clinical variability; they carried six novel mutations, including a deletion of exon 2. However, there were no clear phenotype-genotype correlations.
Disciplines :
Genetics & genetic processes
Author, co-author :
Stalpers, Xenia L.
Verrips, Aad
Poll-The, Bwee Tien
Cobben, Jan-Maarten
Snoeck, Irina N.
de Coo, Irenaeus F. M.
Brooks, Alice
BULK, Saskia ; Centre Hospitalier Universitaire de Liège - CHU > Génétique
Rudnik-Schoneborn S., Stolz P., Varon R., et al. Long-term observations of patients with infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1). Neuropediatrics 2004, 35:174-182.
Wong V.C., Chung B.H., Li S., Goh W., Lee S.L. Mutation of gene in spinal muscular atrophy respiratory distress type 1. Pediatr Neurol 2006, 34:474-477.
Grohmann K., Varon R., Stolz P., et al. Infantile spinal muscular atrophy with respiratory distress type 1 (SMARD1). Ann Neurol 2003, 54:719-724.
Kaindl A.M., Guenther U., Rudnik-Schoneborn S., et al. Spinal muscular atrophy with respiratory distress type 1. J Child Neurol 2008, 23:199-204.
AlSaman A., Tomoum H. Infantile spinal muscular atrophy with respirtory distress type 1: a case report. J Child Neurol 2010, 25:764-769.
Pitt M., Houlden H., Jacobs J., et al. Severe infantile neuropathy with diaphragmatic weakness and its relationship to SMARD1. Brain 2003, 126:2682-2692.
Fanos V., Cuccu A., Nemolato S., Marinelli V., Faa G. A new nonsense mutation of the IGHMB2 gene responsible for the first case of SMARD1 in a Sardinian patient with giant cell hepatitis. Neuropediatrics 2010, 41:132-134.
Grohmann K., Schuelke M., Diers A., et al. Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1. Nat Genet 2001, 29:75-77.
De Planell-Saguer M., Schroeder D.G., Rodicio M.C., Cox G.A., Mourelatos Z. Biochemical and genetic evidence for a role of IGHMBP2 in the translational machinery. Hum Mol Genet 2009, 18:2115-2126.
Guenther U.P., Handoko L., Laggerbauer B., et al. IGHMBP2 is a ribosome-associated helicase inactive in the neuromuscular disorder distal SMA type 1 (DSMA1). Hum Mol Genet 2009, 18:1288-1300.
Fukita Y., Mizuta T.R., Shirozu M., Ozawa K., Shimizu A., Honjo T. The human S mu bp-2, a DNA-binding protein specific to the single-stranded guanine-rich sequence related to the immunoglobulin mu chain switch region. J Biol Chem 1993, 268:17463-17470.
Guenther U.P., Varon R., Schlicke M., et al. Clinical and mutational profile in spinal muscular atrophy with respiratory distress (SMARD): defining novel phenotypes through hierarchical cluster analysis. Hum Mutat 2007, 28:808-815.
Guenther U.P., Handoko L., Varon R., et al. Clinical variability in distal spinal muscular atrophy type 1 (DSMA1): determination of steady-state IGHMBP2 protein levels in five patients with infantile and juvenile disease. J Mol Med 2009, 87:31-41.
Pierson T.M., Tart G., Adams D., et al. Infantile-onset spinal muscular atrophy with respiratory distress-1 diagnosed in a 20-year-old man. Neuromuscul Disord 2011, 21:353-355.
Guenther U.P., Schuelke M., Bertini E., et al. Genomic rearrangements at the IGHMBP2 gene locus in two patients with SMARD1. Hum Genet 2004, 115:319-326.
Grohmann K., Rossoll W., Kobsar I., et al. Characterization of Ighmbp2 in motor neurons and implications for the pathomechanism in a mouse model of human spinal muscular atrophy with respiratory distress type 1 (SMARD1). Hum Mol Genet 2004, 13:2031-2042.
Maddatu T.P., Garvey S.M., Schroeder D.G., Hampton T.G., Cox G.A. Transgenic rescue of neurogenic atrophy in the nmd mouse reveals a role for Ighmbp2 in dilated cardiomyopathy. Hum Mol Genet 2004, 13:1105-1115.
Hartley L., Kinali M., Knight R., et al. A congenital myopathy with diaphragmatic weakness not linked to the SMARD1 locus. Neuromuscul Disord 2007, 17:174-179.
Logan C.V., Lucke B., Pottinger C., et al. Mutations in MEGF10, a regulator of satellite cell myogenesis, cause early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD). Nat Genet 2011, 43:1189-1192.
